Tag Archives: electronics

4 Strong Buy Technology Mutual Funds

More often than not, the technology sector reports above par earnings than other sectors fueled by the demand for technology and innovation. However, technology stocks are considered to be more volatile than other sector stocks in the short run. In order to minimize this short-term volatility, almost all tech funds adopt a growth management style with focus on strong fundamentals and a relatively broader investment horizon. Investors having an above par appetite for risk and a fairly longer investment horizon should park their savings in these funds. Below, we will share with you four buy-rated technology mutual funds . Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) as we expect these mutual funds to outperform their peers in the future. Fidelity Advisor Electronics A (MUTF: FELAX ) seeks capital appreciation. FELAX invests a large portion of its assets in common stocks of companies whose primary operations are related to electronic components, equipment vendors, electronic component manufacturers, electronic component distributors, electronic instruments and electronic systems vendors. Investments are made in both domestic and foreign companies. FELAX uses a fundamental analysis to select companies for investment purposes. The Fidelity Advisor Electronics A is non-diversified and has a three-year annualized return of 16.4%. FELAX has an expense ratio of 1.27% as compared to the category average of 1.42%. Putnam Global Technology A (MUTF: PGTAX ) invests in common stocks of both mid and large-sized companies across the world. PGTAX invests a major portion of its assets in securities of companies in the technology industries. The Putnam Global Technology A is non-diversified and has a three-year annualized return of 13.1%. As of March 2016, PGTAX held 68 issues with 12.76% invested in Alphabet Inc C. Fidelity Select Software & Comp Portfolio (MUTF: FSCSX ) seeks growth of capital. FSCSX invests a major portion of its assets in companies whose primary operations are related to software or information-based services. FSCSX primarily focuses on acquiring common stocks of both domestic and foreign companies. FSCSX uses fundamental analysis to select companies for investment purposes. The Fidelity Select Software & Comp Portfolio is non-diversified and has a three-year annualized return of 14.6%. FSCSX has an expense ratio of 0.76% as compared to the category average of 1.42%. MFS Technology B (MUTF: MTCBX ) invests a large chunk of its assets in securities of companies involved in operations related to products and services that are believed to benefit from advancement and improvement of technology. MTCBX invests in securities issued throughout the globe including those from emerging markets. MFS Technology B is a non-diversified fund and has a three-year annualized return of 12.8%. Matthew D. Sabel is the fund manager since 2011. Original Post

The V20 Portfolio: Week 33

The V20 portfolio is an actively managed portfolio that seeks to achieve an annualized return of 20% over the long term. If you are a long-term investor, then this portfolio may be for you. You can read more about how the portfolio works and the associated risks here . Always do your own research before making an investment. Read the last update here . Note: Current allocation and planned transactions are only available to premium subscribers . Over the past week, the V20 Portfolio rose by 3.8% while the SPDR S&P 500 ETF (NYSEARCA: SPY ) increased by 0.4%. Portfolio Update Conn’s (NASDAQ: CONN ) was responsible for most of the gains this week, rising 15.8% from $10 to $11.58. There were no major events other than a credit facility amendment on Friday, so much of this rally can be attributed to shifting sentiment in the market. Some of the amendments relaxed covenants while others were more restrictive. Let’s go over the restricting amendments first. Distributing restricted payments (e.g. dividends, buybacks) will now require a 2.5x interest coverage ratio for two quarters. Borrowing base was reduced by $15 million, which will be waived if interest coverage ratio exceeds 2x for two quarters. Finally, margin on the loan was increased by 25 bps (i.e. making the revolver a bit more expensive). While none of the amendments were crippling, the amendment concerning restricted payments will prevent Conn’s from making any share repurchases in the coming months, as the interest coverage ratio was less than 2.5x for Q4. The positive amendments included eliminating the minimum interest coverage ratio covenant for Q1 and lowering the total coverage ratio to 1x from 2x. Overall, this was a slight setback as buybacks will not be a possibility in the near future. Last week we discussed how Intelsat (NYSE: I ) was buying back bonds at a discount. For whatever reason (possibly the increased likely hood of a rate hike), the bonds in question declined in value from $70s to high $60s. As such, Intelsat lowered its consideration accordingly, lowering the offer by around 500 bps. Our helicopter company was the portfolio’s major laggard. There was no major development. As discussed in last week’s update, the oil and gas division will continue to battle industry wide headwinds, though the recent bounce in commodities may cushion the fall. However, it is unlikely that revenue will suddenly recover to its previous level as the oil and gas industry overall is still at a cost cutting stage. The medical segment should continue to generate profits, as it will not be affected by the commodity downturn. Risk Management Due to additional capital being allocated to Conn’s and its subsequent rally, the position now accounts for more than 10% of the entire portfolio. For a position to account for such a significant portion, it must fulfill two criteria: high expected rate of return and low probability of permanent capital loss. As we’ve seen with Dex Media, even though the shares were undervalued, 100% of the investment will likely be written off. But by allocating a small amount of capital to this speculative position, it only had a tiny impact on the overall portfolio. Conn’s on the other hand fulfills both criteria. It is not under any significant financial distress and is still growing its business. While short-term results have dampened its profitability, its long-term outlook remains bright. Performance Since Inception Click to enlarge Disclosure: I am/we are long CONN, I. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article.

Lessons From Muddy Waters Research And Other Short-Sellers In Avoiding Potential Value Traps

I recently read this book “The Most Dangerous Trade: How Short Sellers Uncover Fraud, Keep Markets Honest, and Make and Lose Billions” written by Richard Teitelbaum where he profiles 10 high-profile short-sellers including Bill Ackman, Jim Chanos and David Einhorn among others. In particular, the chapter on Carson Block of Muddy Waters Research caught my attention. Carson Block of Muddy Waters Research is best known for his firm’s short-seller reports on Chinese companies. Carson Block embarked on this journey as an activist short-seller with a visit to NYSE-listed Orient Paper (NYSEMKT: ONP ) in January 2010, at the request of his father William Block who operated an investment research firm called WAB Capital which was compensated by listed companies for publishing research reports. During the visit, Carson Block spotted a couple of red flags, including the inconsistency between the actual raw materials (20-foot pile of used paper which was used as feedstock) sighted and its accounting value on the company’s books, the condition of the fixed assets (“the rolling machinery was antiquated”), and the fact that management was apparently unable to answer questions relating to operational metrics during the meeting. He published a negative report on Orient Paper and distributed it via email in June 2010; the stock is currently trading at a fraction of its share price prior to the report. In the next few years, Carson Block started Muddy Waters Research and went on to publish more reports on companies such as Sino-Forest and Rino International. On Muddy Waters Research’s website, the firm highlights its track record , where it claims its nine “Strong Sell” Reports have led to four de-listings, four resignations of auditors/CFO/board members and more than six formal investigations by regulators into covered companies. Lessons From Muddy Waters In September 2014, Carson Block of Muddy Waters Research gave a presentation to accounting students at Baruch College, the presentation slides are available for download here . Carson Block highlighted a couple of red flags that investors should take note of: High Days Sales Outstanding Few tangible assets on balance sheet Highly acquisitive / high capex Outsized gross margins inconsistent with the value-add they are providing to customers Unique in reliance on intermediary counterparties Often (successfully) entering new businesses High revenue or expense concentrations with counterparties Unexplained cash in the Variable Interest Entity Business models that don’t make sense Opaque business model Tax preferences / rates that don’t hold up Obfuscating answers on conference calls Changing Key Performance Indicators Initiatives disappearing without mention Heavy insider selling Losing customers as evidenced by changing names of top 10 customers Significant customer and/or supplier is a related party Inventory turnover inconsistent with industry peers I will elaborate on some of these red flags in greater detail below with actual case studies. Highly acquisitive In 2011, it was reported that Olympus ( OTCPK:OCPNY ), a Japanese manufacturer of cameras and other electronics, utilized acquisition payments and associated fees to hide the fact that it had made severe losses on its investments. The writing was on the wall, for those who bothered to do due diligence, as the company was a serial acquirer buying companies at inflated valuations, only to write down some of these acquisitions in a short period of time. Furthermore, most of these acquired companies were in industries unrelated to Olympus’ core business and were loss-making. Outsized Gross Margins Longtop Financial, a software company with banks and other financial institutions in China as its clients, was the subject of a negative report by Citron Research in April 2011. One of the red flags highlighted by Citron Research was that Longtop reported outsized gross margins of 69% in FY2010, compared with gross margins between 15% and 50% for its peers. According to Citron Research, management’s explanation for the higher gross margin was that “they have more standardized software sales then peers and standardized software has very high gross margins of around 90%. The company claims that these solutions and modules can be deployed to new customers with fewer man-hours and expenses.” In May 2011, Longtop’s auditor resigned; and the company’s shares were suspended from trading in August 2011 by NYSE. Opaque Business Model Charlie Munger has this particular quote which I like a lot: Where you have complexity, by nature you can have fraud and mistakes. You’ll have more of that than in a company that shovels sand from a river and sells it. This will always be true of financial companies, including ones run by governments. If you want accurate numbers from financial companies, you’re in the wrong world. Certain industries and businesses are inherently more complex and opaque, making it difficult for investors and even auditors to understand and do decent work on them. It is telling that several vegetable farming/processing companies in China have been the target of short-sellers at any one point in time or another; see the reports published here and here . On e key risk factor with investing in companies operating in the Chinese agricultural industry is that both sales (to distributors) and purchases (from farmers) are usually transacted in cash without supporting documents such as receipts. Inventory turnover inconsistent with industry peers China Biotics, a manufacturer and distributor of probiotics products, reported inventory turnover ratios of 33 and 29 times in FY2009 and FY2010 respectively, while a March 2011 report published by China Economic Review mentioned that “During our visit to Shanghai Shining Biotechnology’s facility, we saw no evidence of inventory leaving the premises or clients coming for inquiries.” In June 2011, both the auditor and CFO of China Biotics resigned. Closing Thoughts I am a long-only investor and I do not engage in any short-selling. Munger’s quote below echoes my view: It would be one of the most irritating experiences in the world to do a lot of work to uncover a fraud and then watch it go from X to 3X and watch the crooks happily partying with your money while you’re meeting margin calls. Why would you want to go within hailing distance of that? Nevertheless, investing in value traps, particularly those that are or will be the target of short-sellers, is the single easiest way to lose money with stocks. Therefore, investors should actively learn from short-sellers and draw on their knowledge and experience to minimize the possibility of total capital impairment with any single one of their positions. As a special bonus for my subscribers, they will get access to a list of close to 100 Asian and U.S. stocks with large positive accruals (divergence between earnings and cash flow) and high Beneish M-Scores (these two are good indicators of fraud risks) in a separate bonus watchlist article. For readers interested in further exploring this topic, I have also previously written two articles on value traps, namely “How To Avoid Potential Value Traps With Net-Nets And Other Deep Value Stocks” and “Drawing Inspiration From Short-Sellers In Avoiding Potential Value Traps” published here and here respectively. Note: I flag potential value traps with corporate governance issues, financial statement manipulation risks and other red flags as part of my Asia/U.S. Deep-Value Wide-Moat Stocks exclusive research service. My subscribers get access to the list of value traps for both deep value & wide moat stocks, in addition to monthly top ideas, potential investment candidate profiles and potential investment candidate watchlists. Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it. I have no business relationship with any company whose stock is mentioned in this article. Editor’s Note: This article discusses one or more securities that do not trade on a major U.S. exchange. Please be aware of the risks associated with these stocks.